(Q43748726)

26 November 2017

Assessment of motor behavior using a video system and a clinical rating scale in parkinsonian monkeys lesioned by MPTP. (English)

1 reference

26 November 2017

1 reference

Chassain C

1

1 reference

PubMed ID

11574115

26 November 2017

Eschalier A

series ordinal

2

1 reference

PubMed ID

11574115

26 November 2017

Durif F

series ordinal

3

1 reference

26 November 2017

1 October 2001

1 reference

Journal of Neuroscience Methods

26 November 2017

1 reference

26 November 2017

111

1 reference

26 November 2017

9-16

1 reference

26 November 2017

1

1 reference

Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

A chronic MPTP model reproducing the slow evolution of Parkinson's disease: evolution of motor symptoms in the monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

Excitotoxic lateral pallidotomy does not relieve L-dopa-induced dyskinesia in MPTP parkinsonian monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

Chronic exposure to MPTP as a primate model of progressive parkinsonism: a pilot study with a free radical scavenger

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

Stable parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

1 reference

7 January 2021

Comparison of eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the Macaque monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

Effects of talipexole on motor behavior in normal and MPTP-treated common marmosets

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

Oral levodopa dose-response study in MPTP-induced hemiparkinsonian monkeys: assessment with a new rating scale for monkey parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

MRI detects acute degeneration of the nigrostriatal dopamine system after MPTP exposure in hemiparkinsonian monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

Effects of SIB-1508Y, a novel neuronal nicotinic acetylcholine receptor agonist, on motor behavior in parkinsonian monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

Striatal dopamine deficiency in Parkinson's disease: role of aging

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

Approach, avoidance, and contact behavior of individually recognized animals automatically quantified with an imaging technique

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0270%2801%2900425-3

7 January 2021

10.1016/S0165-0270(01)00425-3

Identifiers

DOI

1 reference

26 November 2017

1 reference

PubMed ID

11574115